Noradrenaline (Base) Aguettant Injection
Norepinephrine (Noradrenaline)
1mg/ml
LABORATOIRE AGUETTANT
| Pack size | 4ml Ampoule x 10 |
|---|---|
| Dispensing mode | POM |
| Source | FRANCE |
| Agent | PHARMALINK |
| Retail Price | 95.50 AED |
Indications
Noradrenaline (Base) Aguettant Injection is used for:
Acute Hypotension, Cardiac Arrest, Sepsis & Septic Shock
Adult Dose
Intravenous
Adult:
Acute Hypotension, Cardiac Arrest
Initial: 8-12 mcg/min IV infusion; titrate to effect
Maintenance: 2-4 mcg/min IV infusion
Sepsis & Septic Shock
0.01-3 mcg/kg/min IV infusion
Child Dose
Child:
Acute Hypotension, Cardiac Arrest
Initial: 0.05-0.1 mcg/kg/min IV infusion; titrate to effect
Maximum: 1-2 mcg/kg/min
Shock
0.05-0.1 mcg/kg/min IV infusion; titrate to effect; not to exceed 2 mcg/kg/min
Renal Dose
Administration
IV Preparation & Administration
Infuse using a solution of 4 mcg/ml in glucose 5%, or sodium chloride 0.9% and glucose 5% at a rate of 2-3 ml/minute. Adjust according to BP response. Average maintenance dose: 0.5-1 ml/minute (2-4 mcg/minute). Infuse via a central venous catheter or into a large vein.
Contra Indications
Hypersensitivity. Hypertension. Pregnancy. Patients with peripheral or mesenteric vascular thrombosis unless necessary as a life-saving procedure.
Concomitant use with some general anesthetics: Chloroform, trichloroethylene, cyclopropane, halothane
Precautions
Not a substitute for replacement of blood, plasma, fluids, and/or electrolytes; correct volume depletion prior to admin. Identify and correct hypoxia, hypercapnia and acidosis prior to or during admin. Avoid extravasation as tissue necrosis may occur. Avoid inj into leg veins, especially in elderly or those with occlusive vascular diseases, arteriosclerosis, DM or Buerger's disease. Hypertensive or hyperthyroid patients. In conjunction with local anaesthetics, do not use in fingers, toes, ears, nose or genitalia. Lactation.
Lactation: Not known if excreted into breast milk; avoid use during breastfeeding
Pregnancy-Lactation
Interactions
Guanethidine, methyldopa, reserpine, TCAs may increase pressor response to norepinephrine.
Potentially Fatal: Increased risk of arrhythmias with cocaine, cyclopropane or halogenated hydrocarbon anaesthetics. Hypertensive crisis may occur with MAOIs. Hypertensive effects may be increased by nonselective β-blockers.
Adverse Effects
Side effects of Norepinephrine (Noradrenaline) :
Hypertension, headache, peripheral ischaemia, bradycardia, arrhythmias, anxiety, skin necrosis (with extravasation), dyspnoea, respiratory difficulty.
Mechanism of Action
Norepinephrine is a direct-acting sympathomimetic which stimulates alpha 1- and beta-adrenergic receptors. Its alpha-agonist effects cause vasoconstriction, thereby raising systolic and diastolic BP with reflex slowing of heart rate.
Note
Noradrenaline (Base) Aguettant 1mg/ml Injection manufactured by LABORATOIRE AGUETTANT. Its generic name is Norepinephrine (Noradrenaline). Noradrenaline (Base) Aguettant is availble in United Arab Emirates.
Farmaco UAE drug index information on Noradrenaline (Base) Aguettant Injection is not intended for diagnosis, medical advice or treatment; neither intended to be a substitute for the exercise of professional judgment.